152 related articles for article (PubMed ID: 3332574)
41. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy.
Rahima-Maoz C; Grossman E; Nussinovitch N; Katz A; Rosenthal T
Cardiology; 1997; 88 Suppl 3():43-6. PubMed ID: 9397293
[TBL] [Abstract][Full Text] [Related]
42. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Murdoch D; Brogden RN
Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of two different formulations of nifedipine (GITS) vs. slow release microgranules in patients with mild and moderate hypertension.
Botero R; Aroca G; Asa G; González M
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S156-60. PubMed ID: 11986916
[TBL] [Abstract][Full Text] [Related]
44. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
[TBL] [Abstract][Full Text] [Related]
45. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
Khan AU
J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
[TBL] [Abstract][Full Text] [Related]
46. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
47. Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
Wallace WA; Wellington KL; Chess MA; Liang CS
Am J Cardiol; 1994 Jan; 73(1):23-8. PubMed ID: 8279372
[TBL] [Abstract][Full Text] [Related]
48. Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE).
Motaweih AK; Usova E; Hussain W; Dello Z; Petri T
Clin Exp Hypertens; 2016; 38(1):71-80. PubMed ID: 26331311
[TBL] [Abstract][Full Text] [Related]
49. Nifedipine gastrointestinal therapeutic system.
Swanson DR; Barclay BL; Wong PS; Theeuwes F
Am J Med; 1987 Dec; 83(6B):3-9. PubMed ID: 3503595
[TBL] [Abstract][Full Text] [Related]
50. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
Vandongen R; Beilin LJ; Lalor C; Wall BP
Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
[TBL] [Abstract][Full Text] [Related]
51. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.
Brogden RN; McTavish D
Drugs; 1995 Sep; 50(3):495-512. PubMed ID: 8521771
[TBL] [Abstract][Full Text] [Related]
52. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
Chung M; Reitberg DP; Gaffney M; Singleton W
Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
[TBL] [Abstract][Full Text] [Related]
53. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
[TBL] [Abstract][Full Text] [Related]
54. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
55. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system.
Testa MA; Hollenberg NK; Anderson RB; Williams GH
Am J Hypertens; 1991 Apr; 4(4 Pt 1):363-73. PubMed ID: 2059396
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness of combined nifedipine and propranolol treatment in hypertension.
Yagil Y; Kobrin I; Stessman J; Ghanem J; Leibel B; Ben-Ishay D
Hypertension; 1983; 5(4 Pt 2):II113-7. PubMed ID: 6862585
[TBL] [Abstract][Full Text] [Related]
57. Effect of lacidipine and nifedipine GITS on platelet function in patients with essential hypertension.
Armas-Padilla MC; Armas-Hernández MJ; Hernández-Hernández R; Velasco M; Pacheco B; Carvajal AR; Castillo-Moreno A
J Hum Hypertens; 2000 Apr; 14 Suppl 1():S91-5. PubMed ID: 10854087
[TBL] [Abstract][Full Text] [Related]
58. Formulation of long-acting nifedipine tablets influences the heart rate and sympathetic nervous system response in hypertensive patients.
Brown MJ; Toal CB
Br J Clin Pharmacol; 2008 May; 65(5):646-52. PubMed ID: 18093252
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of nifedipine gastrointestinal therapeutic system for treatment of hypertension: results of the MATH Trial.
Krakoff LR
J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S14-7. PubMed ID: 7692145
[TBL] [Abstract][Full Text] [Related]
60. Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses.
Kjeldsen SE; Cha G; Villa G; Mancia G;
J Clin Pharmacol; 2016 Sep; 56(9):1120-9. PubMed ID: 26829251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
